Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · IEX Real-Time Price · USD
34.67
-0.16 (-0.47%)
Mar 28, 2024, 11:19 AM EDT - Market open

IART Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Revenue
1,5421,5581,5421,3721,5181,4721,188992.08882.73796.72
Upgrade
Revenue Growth (YoY)
-1.03%0.99%12.43%-9.60%3.06%23.92%19.77%12.39%10.80%14.33%
Upgrade
Cost of Revenue
656.84587.36597.81520.83564.68571.5435.51349.09326.54302.95
Upgrade
Gross Profit
884.74970.31944.64851.03952.88900.95752.73642.99556.19493.77
Upgrade
Selling, General & Admin
656.64616.32637.45594.53687.6690.75624.1455.63415.76375.55
Upgrade
Research & Development
104.19101.1993.0577.3879.5778.0463.4658.1650.943.56
Upgrade
Other Operating Expenses
12.3813.8816.9127.7691.9421.1620.3713.869.956.81
Upgrade
Operating Expenses
773.21731.39747.41699.66859.12789.95707.92527.65476.61425.91
Upgrade
Operating Income
111.53238.92197.23151.3793.7611144.8115.3479.5967.86
Upgrade
Interest Expense / Income
51.3849.5950.471.5853.9664.6835.0225.823.5321.97
Upgrade
Other Expense / Income
-20.92-24.57-67.84-13.73-20.3-11.09-1.6-0.875.752.62
Upgrade
Pretax Income
81.07213.89214.6893.5260.157.411.3990.4150.343.28
Upgrade
Income Tax
13.3333.3445.6-40.379.9-3.4-53.3615.8453.829.27
Upgrade
Net Income
67.74180.55169.08133.8950.260.864.7474.56-3.5234
Upgrade
Net Income Growth
-62.48%6.79%26.28%166.71%-17.43%-6.09%-13.17%---
Upgrade
Shares Outstanding (Basic)
80838585868377746965
Upgrade
Shares Outstanding (Diluted)
80848585868479797166
Upgrade
Shares Change
-3.81%-2.30%0.30%-1.46%2.97%6.17%-0.09%10.99%8.24%14.44%
Upgrade
EPS (Basic)
0.852.182.001.580.590.730.841.00-0.050.52
Upgrade
EPS (Diluted)
0.842.161.981.570.580.720.820.94-0.050.52
Upgrade
EPS Growth
-61.11%9.09%26.11%170.69%-19.44%-12.20%-12.77%---
Upgrade
Free Cash Flow
73.09233.27264.41168.6161.93122.3671.3369.3972.8845.23
Upgrade
Free Cash Flow Per Share
0.912.813.121.991.891.480.930.931.060.70
Upgrade
Gross Margin
57.39%62.29%61.24%62.03%62.79%61.19%63.35%64.81%63.01%61.98%
Upgrade
Operating Margin
7.23%15.34%12.79%11.03%6.18%7.54%3.77%11.63%9.02%8.52%
Upgrade
Profit Margin
4.39%11.59%10.96%9.76%3.31%4.13%5.45%7.52%-0.40%4.27%
Upgrade
Free Cash Flow Margin
4.74%14.98%17.14%12.29%10.67%8.31%6.00%6.99%8.26%5.68%
Upgrade
Effective Tax Rate
16.44%15.59%21.24%-43.17%16.48%-5.92%-468.67%17.52%107.00%21.42%
Upgrade
EBITDA
258.15384.6388.74284.09228.58232.82135.35188.87132.7111.68
Upgrade
EBITDA Margin
16.75%24.69%25.20%20.71%15.06%15.81%11.39%19.04%15.03%14.02%
Upgrade
Depreciation & Amortization
125.7121.12123.67118.99114.52110.7388.9572.6758.8646.43
Upgrade
EBIT
132.45263.49265.07165.1114.06122.0946.4116.2173.8465.24
Upgrade
EBIT Margin
8.59%16.92%17.19%12.03%7.52%8.29%3.91%11.71%8.36%8.19%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).